Patrice Morand
Papers
1
Total Citations
28
H-Index
1
About
Patrice Morand is a leading virologist whose work has significantly advanced the clinical management of Epstein-Barr virus (EBV) infections, particularly in immunocompromised patients. His research centers on the development and optimization of molecular diagnostic tools for EBV, with a focus on improving the accuracy and reliability of viral load quantification. Morand’s most cited study, “Evaluation of the Epstein-Barr Virus R-Gene Quantification Kit in Whole Blood with Different Extraction Methods and PCR Platforms” (2007, 28 citations), is a cornerstone in the field, demonstrating how variations in laboratory techniques can impact EBV detection—a critical insight for transplant recipients and patients with EBV-associated lymphoproliferative disorders. This work has helped standardize protocols, enabling more consistent monitoring of viral reactivation and treatment response. Beyond this, Morand has contributed to understanding EBV pathogenesis and its role in post-transplant complications, influencing clinical guidelines. His meticulous approach to assay validation has made him a trusted authority in virology, bridging the gap between research and bedside practice. For students and researchers, Morand’s career exemplifies how rigorous method evaluation can directly improve patient outcomes in infectious disease management.
Research Focus
Key Achievements
Top Papers
- 1